Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 2, 2014, Pages 728-732

  Ding, Zhong Yang ^a   Wu, Hao Rong ^b   Zhang, Jia Ming ^a   Huang, Guo Rong ^a   Ji, Dong Dong ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

CDC20; Gastric cancer; Immunohistochemistry

Indexed keywords

EID: 84894036102     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Zhang YZ, Zhang LH, Gao Y, Li CH, Jia SQ, Liu N, Cheng F, Niu DY, Cho WC, Ji JF and Zeng CQ. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol 2011; 17: 1710-7.
4. Jia YF, Xiao DJ, Ma XL, Song YY, Hu R, Kong Y, Zheng Y, Han SY, Hong RL and Wang YS. Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1α and Ki67 in human gastric cancer. Diagn Pathol 2013; 8: 37.
5. Jin J, Jin T, Quan M, Piao Y and Lin Z. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagn Pathol 2012; 7: 135.
6. Sotoudeh K, Hashemi F, Madjd Z, Sadeghipour A, Molanaei S and Kalantary E. The clinicopathologic association of c-MET overexpression in Iranian gastric carcinomas; an immunohistochemical study of tissue microarrays. Diagn Pathol 2012; 7: 57.
7. Weinstein J, Jacobsen FW, Hsu-Chen J, Wu T and Baum LG. A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4. Mol Cell Biol 1994; 14: 3350-63.
8. Rajagopalan H and Lengauer C. Aneuploidy and cancer. Nature 2004; 432: 338-41.
9. Wu WJ, Hu KS, Wang DS, Zeng ZL, Zhang DS, Chen DL, Bai L and Xu RH. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. J Transl Med 2013; 11: 142.
10. Wu WJ, Hu KS, Wang DS, Zeng ZL, Zhang DS, Chen DL, Bai L and Xu RH. CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer. J Transl Med 2013; 11: 142.
11. Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M and Kaji M. Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients. J Surg Oncol 2012; 106: 423-30.
12. Bie L, Zhao G, Cheng P, Rondeau G, Porwollik S, Ju Y, Xia XQ and McClelland M. The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression. PLoS One 2011; 6: e25631.
13. Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS and Roychoudhury S. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 2007; 28: 81-92.
14. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F and Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-64.
15. Zhao ZS, Wang YY, Chu YQ, Ye ZY and Tao HQ. SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2010; 16: 260-8.